With her background in biology, specialized in human and animal physiology and toxicology, with 20 years of CRO experience, including 14 years more specifically in applied genetic toxicity testing, Annie has experience directing over than 400 in vitro and in vivo safety genetic toxicology assessment studies. She has high experience in the in vivo assays, the comet assay field, in vitro 3D cell culture models and organ-on-chip microfluidic system. She was responsible of development and implementation of new assays in addition to software validation for automation implementation.
Annie Hamel
